Differential Analysis of the Frequency-Dependent Effects of Class 1 Antiarrhythmic Drugs According to Periodical Ligand Binding
- 1 June 1990
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 15 (6) , 998-1009
- https://doi.org/10.1097/00005344-199006000-00019
Abstract
The frequency-dependent block of cardiac sodium channels by class 1 antiarrhythmic drugs can be described by a periodical ligand binding process between drug molecules and channel binding sites. This predicts a linear relation between onset-rate constant of frequency-dependent block and diastolic interval as well as saturation of block with high stimulation rates. From both relationships, the binding kinetics (time constant, .tau.on) and saturation level of block (bdinf) can be estimated. This is examplified for the frequency-dependent block (reduction of the maximal upstroke velocity of action potentials) induced by prajmaline (10-6M). In the same way, the frequency-dependent effects of 11 other class 1 drugs reported in the literature were analyzed and compared with each other. When the drugs are ranked with respect to their binding kinetics (.tau.on), there is a close relationship to the subclasses (1a, 1b, 1c), with 1b drugs exhibiting the fastest and 1c drugs the slowest kinetics. However, differences also exist in the saturation behavior of frequency-dependent block even within the same subclasses (1a and 1c). Thus, the class 1 drugs can also be subdivided in three other groups exhibiting clearly separated bands of block-frequency relations, with half-maximal satruation occuring at different stimulation rates. Our findings may have differential implications for the antiarrhythmic and proarrhythmic efficacy of class 1 drugs.This publication has 28 references indexed in Scilit:
- Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainideCardiovascular Research, 1983
- Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.Circulation, 1983
- Mechanisms of quinidine-induced depression of maximum upstroke velocity in ovine cardiac Purkinje fibers.Circulation Research, 1982
- Effects of disopyramide on the maximum rate of rise of action potential (Vmax) in guinea-pig papillary muscles.The Japanese Journal of Pharmacology, 1982
- Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary musclesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1980
- Test of a model of antiarrhythmic drug action. Effects of quinidine and lidocaine on myocardial conduction.Circulation, 1980
- Inhibiton of $$\dot V_{\max } $$ of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardiumNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1980
- Effect of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentrationNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Antifibrillatory actionThe Journal of Physiology, 1962
- A quantitative description of membrane current and its application to conduction and excitation in nerveThe Journal of Physiology, 1952